| English Alias: |
Fluorouracil;1-FLUORO-1H-PYRIMIDINE-2,4-DIONE;2,4-DIHYDROXY-5-FLUOROPYRIMIDINE;5-FLUORO-1H-PYRIMIDINE-2,4-DIONE;5-FLUORO-2,4(1H,3H)-PYRIMIDINEDIONE;5-FLUORO-2,4-DIHYDROXYPYRIMIDINE;5-fluoro-2,4-pyrimidinedione;5-FLUOROPYRIMIDINE-2,4(1H,3H)-DIONE;5-Fluoropyrimidine-2,4-dione;5-FU;[180]-5-Fluorouracil;2,4(1H,3H)-Pyrimidinedione, 5-fluoro-;2,4-dioxo-5-fluoropyrimidine;3h)-pyrimidinedione,5-fluoro-4(1h;5-faracil;5-Flouracyl;5-fluor-2,4(1h,3h)-pyrimidindion;5-Fluor-2,4-dihydroxypyrimidin;5-Fluorouracil;5-Fluorouracil (5-FU, 5-Fluoracil);Fluorouracil (5-Fluoracil, 5-FU);2,4-Dihydroxy-5-fluoropyrimidine,5-FU,5-Fluoro-2,4(1H,3H)-pyrimidinedione;2,4-Dihydroxy-5-fluoropyriMidine;5-fluoro-2,4-dioxopyrimidine;5-fluoro-uracile;Arumel;Efudex;Efudix;Efurix;Fluri;Fluril;U-8953;Ulup;Fluoroplex;Adrucil;Carac;Fluracil;Fluoroblastin;Kecimeton;Carzonal;Timazin;5-Fluoracil;Queroplex;Fluracilum;Phthoruracil;Fluro Uracil;Fluorouracilum;Ftoruracil;5 Fluorouracil;Effluderm (free base);Fluorouracilo;Fluroblastin;Phtoruracil;F;Fluoroplex (TN);FLUOROURACIL [MI];s1209;5-fluoro-pyrimidine-2,4-diol;DTXSID2020634;AKOS008044307;NCGC00015442-08;HMS2091F19;NCGC00015442-04;5 FU;5-Fluoruracil;FLUOROURACIL [USP-RS];Spectrum_000841;5-fluorpyrimidin-2,4-diol;2,3H)-Pyrimidinedione, 5-fluoro-;A7567;SPBio_000291;BCP9000239;KBioSS_001321;U3P01618RT;5-Fluoro-1H-pyrimidine-2,4-dione (5-FU);5-Fluoruracil [German];U 8953;Fluorouracil, European Pharmacopoeia (EP) Reference Standard;5-Fluorouracil, analytical standard;EINECS 200-085-6;CHEBI:46345;5-Fluorouracil, certified reference material, TraceCERT(R);1004-03-1;BRD-K24844714-001-02-1;NCGC00015442-09;5-fluoro uracil;NCGC00015442-07;NCGC00254023-01;HMS500C16;FLUCYTOSINE IMPURITY A [EP IMPURITY];2,4-Pyrimidinedione, 5-fluoro-;EU-0100536;Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material;WLN: T6MVMVJ EF;5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU);51-21-8;FLUOROURACIL [USAN];KS-5129;Q238512;Fluorouracil Cream;FLUOROURACIL [INN];NCGC00015442-03;NCI60_001652;BCPP000428;HMS3654K22;Tox21_110150_1;FLUOROURACILUM [WHO-IP LATIN];HMS3865L03;5-Fluorouracil, 99%;Ro-29757;AKOS003237897;Folfox component fluorouracil;NCGC00091349-07;FLUCYTOSINE IMPURITY A (EP IMPURITY);SRI-10792_07;FLUOROURACIL [JAN];BDBM50340677;Fluorouracil, British Pharmacopoeia (BP) Reference Standard;pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen;4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy- (9CI);Tolak;191047-64-0;EMTRICITABINE IMPURITY F [WHO-IP];5-Fluorouracil, >=99% (HPLC), powder;KBio2_006457;HMS3715H03;5F-uracil;UPCMLD-DP130:001;HY-90006;HMS3259O03;NS00000337;SBI-0050519.P004;Lopac-F-6627;AKOS000119162;Fluorouracil (JP17/USP/INN);5-FLUOROURACIL (IARC);Spectrum3_000434;5-Fluoracil [German];inhibits thymilidate synthetase;FT-0668745;Fluorouracil, United States Pharmacopeia (USP) Reference Standard;Fluorouracil... |
(%5bF-%5d)(%5bF-%5d)%5bF-%5d.C%5bN%2b%5d1(CCCC1)C)
Borate(1-), bis[1,2-benzenediolato(2-)-κO1,κO2]-, lithium (1:1), (T-4)-
Cas No: 156762-86-6
